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IL-17A both initiates, via IFNγ suppression, and limits the
pulmonary type-2 immune response to nematode infection
Jesuthas Ajendra1,2, Alistair L. Chenery1,2, James E. Parkinson1,2, Brian H. K. Chan1,2, Stella Pearson1,2, Stefano A. P. Colombo1,2,3,
Louis Boon4, Richard K. Grencis1,2, Tara E. Sutherland1 and Judith E. Allen 1,2
Nippostrongylus brasiliensis is a well-defined model of type-2 immunity but the early lung-migrating phase is dominated by innate
IL-17A production. In this study, we confirm previous observations that Il17a-KO mice infected with N. brasiliensis exhibit an
impaired type-2 immune response. Transcriptional profiling of the lung on day 2 of N. brasiliensis infection revealed an increased
Ifng signature in Il17a-KO mice confirmed by enhanced IFNγ protein production in lung lymphocyte populations. Depletion of early
IFNγ rescued type-2 immune responses in the Il17a-KO mice demonstrating that IL-17A-mediated suppression of IFNγ promotes
type-2 immunity. Notably, later in infection, once the type-2 response was established, IL-17A limited the magnitude of the type-2
response. IL-17A regulation of type-2 immunity was lung-specific and infection with Trichuris muris revealed that IL-17A promotes a
type-2 immune response in the lung even when infection is restricted to the intestine. Together our data reveal IL-17A as a major
regulator of pulmonary type-2 immunity such that IL-17A supports early development of a protective type-2 response by
suppression of IFNγ but subsequently limits excessive type-2 responses. A failure of this feedback loop may contribute to conditions
such as severe asthma, characterised by combined elevation of IL-17 and type-2 cytokines.
Mucosal Immunology _#####################_ ; https://doi.org/10.1038/s41385-020-0318-2
INTRODUCTION
Innate and adaptive sources of interleukin-17A (IL-17A) are
responsible for a range of neutrophil-associated inflammatory
conditions as well as protection from many bacterial and fungal
pathogens.1,2 In contrast, type-2 immunity is required for
effective control of most helminth infections3 and is character-
ized by eosinophilic inflammation and the cytokines IL-4, IL-5
and IL-13. When both type-2 and IL-17 responses are present
during helminth infection enhanced pathology is observed, as
shown for human schistosomiasis4,5 and onchocerciasis.6 The
detrimental relationship between IL-17A and type-2 associated
diseases has also been extensively documented in allergic
asthma in which the most severe symptoms occur in patients
with both high Th2 and Th17 cell responses.7 Critically, type-2
cytokines can actively suppress IL-17A production which may be
an important feedback mechanism to avoid extreme IL-17A-
driven pathology.8–10 Despite evidence for an important
relationship between IL-17A and type-2 immune responses
during chronic disease, how these responses are connected
remain poorly understood.
We and others have demonstrated a prominent role for IL-17A
during infection with the lung-migrating nematode Nippostron-
glyus brasiliensis,8,11 a well-defined pulmonary model of type-2
immunity. After entering the host via the skin, N. brasiliensis
larvae migrate through the lung, causing tissue damage and
haemorrhage. IL-17RA-dependent neutrophil recruitment is
largely responsible for the lung damage in this model.11 We
previously found that the chitinase-like protein Ym1 induces
expansion of IL-17A-producing γδ T cells and Ym1 blockade or
IL-17A-deficiency protects mice from peak lung damage.8 More
surprising was our finding that Ym1 neutralisation or IL-17A-
deficiency prevents the development of a full type-2 response
during N. brasiliensis infection.8
The notion that IL-17A is required for development of a type-2
response appears counter to the evidence that type-2 cytokines
suppress IL-17A production.9,10 However, previous studies using
murine models of allergic inflammation also show impaired
type-2 immunity in the face of IL-17A-deficiency12,13
or blockade.14 In an infection or injury context, the specific
tissue as well as timing might all play decisive roles in whether
IL-17A augments or suppresses type-2 responses. We therefore
used N. brasiliensis infection to address the contribution of γδ T
cell-derived IL-17A to the development of a subsequent type-2
immune response in the lung. We found that IL-17A suppressed
early IFNγ production and that this suppression was essential for
the optimal development of a type-2 response. Once the type-2
response was established, IL-17A acted as a negative regulator,
revealing distinct roles during innate and adaptive stages of
the response. Notably, Trichuris muris, a nematode restricted
to the gastro-intestinal tract also induced a lung type-2 response
that was IL-17A-dependent. However, we found no evidence
that IL-17A regulated the intestinal type-2 response. Thus, IL-17A
serves as a lung-specific regulator of the type-2 immune
response.
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RESULTS
IL-17A-deficient mice mount a diminished type-2 response
In keeping with the known ability of N. brasiliensis to induce a
strong pulmonary type-2 immune response on day 6 post
infection (d6pi), we found the bronchoalveolar lavage (BAL) and
lungs of C57BL/6 mice to be dominated by eosinophils
(Supplementary Fig. 1a, b). This response was accompanied by
elevated numbers of CD4+ T cells as well as induction of Group 2
Innate lymphoid cells (ILC2, Supplementary Fig. 1c, d). The
establishment of a type-2 response was further confirmed by
increased type-2 cytokine expression by CD4+ T cells and gene
expression in whole lung (Supplementary Fig. 1e, f). As we and
others previously reported,8,11 infected mice exhibited increased
IL-17A production within the first 48 h post infection (Fig. 1a) and
consistent with previous reports, the main source of IL-17A was γδ
T cells.8 On d2pi the BAL consisted mainly of neutrophils
(Supplementary Fig. 1a), which, together with N. brasiliensis larvae
migration, is known to cause acute lung injury.11
To investigate the role of IL-17A during the development of
type-2 immune responses, we infected Il17a-KO mice and WT
C57BL/6 controls with N. brasiliensis L3’s. Larvae leave the lung
within 48 h and are expelled from the gut within 6–8 days.
Consistent with our previous findings8 Il17a-KO mice were
significantly more susceptible to infection exhibiting an intestinal
worm burden almost two-fold higher than WT controls on d4pi
and d6pi (Fig. 1b). As expected, the early d2 neutrophilia in
response to N. brasiliensis infection was muted in the Il17a-KO
mice relative to the WT controls (Fig. 1c). Between d2pi and d6pi,
there was a switch from neutrophilic to eosinophilic responses in
the lungs (Supplementary Fig. 1a). Whilst increased eosinophil
numbers were observed in all d6 infected mice relative to naïve
animals, this increase was less evident for Il17a-KO mice
(Supplementary Fig. 1g). ILC2s displayed a similar pattern, as cell
numbers significantly increased with infection in WT but not in
Il17a-KO mice (Fig. 1d). In addition, increased expression of the
hallmark type-2 cytokine Il4 was observed at d6pi in WT mice,
whilst Il17a-KO mice had significantly reduced Il4 expression
compared with WT controls (Fig. 1e). Secretion of IL-13 protein
levels at d6pi by total lung cells restimulated with α-CD3 were
significantly higher in WT mice compared with naïve controls,
whilst Il17a-KO mice failed to secrete detectable amounts of IL-13
(Fig. 1f). We also measured expression levels of the major mucins
in the lung because host mucin production is another feature of
protective type-2 responses.15 N. brasiliensis infection drove an
early increase in mucins Muc5ac and Muc5b expression in the
lungs of WT mice at d2pi corresponding to a timepoint when the
larvae are transitioning from the lungs. Expression of both Muc5ac
and Muc5b were increased in WT mice compared with naïve
controls, but reduced in Il17a-KO mice (Supplementary Fig. 1h).
While we observed an impairment in innate type-2 features, we
next aimed to determine whether the impact of IL-17A-deficiency
on type-2 immunity was due to changes in the adaptive immune
response, mainly T cell activation or polarisation during
N. brasiliensis infection. Using flow cytometry, we observed a
failure to induce CD4+ T cells numbers on d7pi in the lungs in
Il17a-KO mice compared with WT controls (Fig. 1g). In contrast,
there were no significant differences in CD4+ T cell numbers in the
lung-draining lymph nodes (Fig. 1g). We also examined expression
of the Th2 transcription factor GATA3. While WT mice showed
a significant increase in absolute numbers and frequency
of GATA3+CD4+ T cells upon infection, Il17a-KO mice had a
significantly lower frequency of GATA3+CD4+ T cells and failed to
upregulate these cells on d7pi compared with WT controls
(Fig. 1h). Not only were there fewer GATA3+ CD4+ T cells in the
lungs of Il17a-KO mice, the CD4+ T cells in Il17a-KO mice produced
significantly less IL-13 and IL-5 (Fig. 1i). Strikingly, by d7pi, IL-5+
and IL-13+ CD4+ T cell numbers did not increase in Il17a-KO
mice in response to infection (Fig. 1j). At the same time point
post-infection, we also found that expression of the activation
marker CD69 was upregulated on CD4+ T cells in the lungs of WT
but not Il17a-KO mice (Fig. 1k). However, CD69 did not differ
between all tested groups in the lung-draining lymph nodes
(Fig. 1l). Recently, Minutti et al. showed that epidermal growth
factor receptor (EGFR) in complex with ST2 on T cells allows for
IL-33-induced IL-13 production at the site of N. brasiliensis
infection.16 We therefore analysed surface expression of EGFR
and ST2 on lung and lung-draining lymph node T cells.
N. brasiliensis infection increased the number of CD4+ T cells
expressing these markers in the lung, but this increase was
significantly reduced in Il17a-KO mice. (Fig. 1k). No significant
changes to ST2 and EGFR expression between WT and KO mice
were observed in the lung-draining-lymph nodes (Fig. 1l). We also
measured PD-1 expression, an important regulator of T cell
function during helminth infection.17,18 N. brasiliensis infection
in WT mice led to increased numbers of CD4+ T cells expressing
PD-1 in the lung and the lung draining lymph node of WT mice
(Fig. 1k, l). However, there were significantly fewer PD-1+ CD4+
T cells in the lungs (Fig. 1k) of infected Il17a-KO mice but not the
lymph node (Fig. 1l). Overall, these data demonstrated a
significant impairment of the type-2 response in the absence of
IL-17A during helminth infection, with lung CD4+ T cells failing to
become fully activated and produce type-2 cytokines.
IL-17A leads to a downregulation of early IFNγ during
Nippostronglyus infection
Rapid early IL-17A production is critical for protective immune
responses in different settings of lung immunity.1,19 To better
understand the early events unfolding in the lung during N.
brasiliensis infection, we performed a Nanostring gene expression
array using a myeloid immunity panel (700 genes). In whole lung,
differentially expressed (DE) genes between naïve WT mice and
infected WT and Il17a-KO mice at d2pi were assessed in total
unamplified RNA (Fig. 2a). IL-17A deficiency led to a distinct gene
expression profile compared with WT mice in response to
N. brasiliensis infection. Notably, when analysing all DE genes
(Fig. 2a) using the Ingenuity pathway analyser (Qiagen), ifng was
predicted as the most significantly increased upstream regulator
in N. brasiliensis infected Il17a-KO compared with WT mice
(Fig. 2b). This led us to hypothesize that IL-17A may suppress
IFNγ, which would facilitate Th2 cell development and explain why
mice deficient in IL-17A cannot induce a full type-2 immune
response. This hypothesis was also consistent with our unpub-
lished and published20 finding that Ym1, which induces IL-17A,
strongly suppresses IFNγ. To test this possibility, we assessed IFNγ
responses in Il17a-KO mice after N. brasiliensis infection. While WT
mice exhibited significant suppression of Ifng in whole lung at
2dpi compared with uninfected controls, mice deficient in IL-17A
did not show this phenotype (Fig. 2c). By intracellularly staining for
IFNγ, we observed that Il17a-KO mice infected with N. brasiliensis
failed to exhibit the early downregulation of IFNγ expression seen
in infected WT mice (Fig. 2d). Importantly, this failure of
suppression was observed across different types of IFNγ-
producing cells. Lung γδ T cells, CD4+ T cells, CD8+ T cells as
well as NK1.1+ natural killer cells from Il17a-KO mice all produced
significantly enhanced IFNγ relative to WT mice (Fig. 2d). We
further assessed whether early IFNγ was produced by γδ T cell
subsets that differ in their expression of CD27 and CD44.21 At 16 h
post N. brasiliensis infection, IFNγ frequencies were also signifi-
cantly increased in γδ T cells of Il17a-KO mice compared with WT
controls (Fig. 2e). Consistent with expectations,21 the CD27+ γδ
T cells were the main producers of IFNγ after infection (Fig. 2f).
Overall, our data demonstrated that IL-17A-deficiency enhanced
IFNγ production during infection, supporting the hypothesis that
IL-17A plays an important role in downregulating IFNγ at the site
of infection during the lung migratory phase of N. brasiliensis
infection.
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IFNγ neutralization in Il17a-KO mice rescues the impaired type-2
immune response
We next asked whether global suppression of early IFNγ by IL-17A
was required for the full development of type-2 immunity in the
lung. IFNγ was neutralised at day −1 and 1 of infection in Il17a-KO
and WT mice, and responses examined at d8pi, a time point when
the type-2 response should be fully developed (Fig. 3a). The
significant defect in eosinophilic responses in Il17a-KO mice
compared with WT mice was still evident at d8pi. However,
blocking IFNγ in Il17a-KO mice enhanced eosinophil numbers
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(Fig. 3b). The same pattern was observed for numbers of CD4+
T cells in the lungs (Fig. 3c). To determine whether IFNγ
neutralisation altered the type-2 response, we assessed expression
of the key type-2 cytokines Il4 and Il13 and the type-2 marker
Chil3. As expected, based on our results thus far, expression of
these genes in the lungs was significantly reduced in infected
Il17a-KO mice compared with WT mice (Fig. 3d, e). Notably, IFNγ
depletion completely recovered expression of these cytokines in
Il17a-KO mice compared with isotype-treated animals, with Il4
expression surpassing the levels seen in WT infected mice (Fig. 3d).
Similarly, analysis of numbers of IL-5 and IL-13 producing CD4+
T cells at d8pi showed complete restoration of the type-2
response in Il17a-KO mice that received the neutralising IFNγ
antibody (Fig. 3f). Consistent with the ability of IFNγ to regulate
type-2 cytokines, IFNγ depletion also restored the activation status
of CD4+ T cells in the Il17a-KO mice as shown by CD69 expression
(Fig. 3g) and increased the numbers of CD4+ T cells expressing
type-2 markers EGFR, PD1 and ST2 (Fig. 3h). Again, no effect was
observed in these parameters in IFNγ-depleted WT mice. Together
these data demonstrate that an initial reduction in IFNγ levels
during N. brasiliensis infection mediated by IL-17A, allows the
subsequent development of type-2 immunity in the lung.
IL-17A suppresses an established type-2 response in the lung
IFNγ depletion in Il17a-KO mice not only restored the type-2
response, but in some cases exceeded WT levels. Therefore, we
hypothesized that although innate IL-17A promotes the establish-
ment of type-2 immunity in N. brasiliensis infection, once the
adaptive response is in place, IL-17 can act to negatively regulate
the type-2 pulmonary response. To test this hypothesis, we
neutralized IL-17A at d4pi, d5pi and d6pi in WT mice and assessed
immune responses at d7pi (Fig. 4a). Blocking of later stage IL-17A
led to a significant increase in both ILC2 numbers and frequencies
in the lung (Fig. 4b), as well as the numbers of ILC2s producing
IL-5 and IL-13 (Fig. 4c). Although CD4+ T cell numbers in the lung
were comparable between isotype-treated and anti-IL-17A-treated
WT mice (Fig. 4d), the ability of CD4+ T cells to produce type-2
cytokines may partly rely on IL-17A, as mice administered anti-IL-
17A showed a slight increase in numbers of CD4+ T cells
producing IL-5 and IL-13 (Fig. 4e). This data demonstrated that
IL-17A can have differential effects depending on the time and
status of infection. While early IL-17A promotes the type-2
response, later in infection IL-17A acts to suppress and limit
excessive type-2 immunity, particularly in ILC2s.
IL-17A does not regulate type-2 immune responses at the site of
T. muris infection
Our data demonstrate an impairment of the type-2 immune
response in the lung during infection of Il17a-KO mice with the
lung-migrating nematode N. brasiliensis. We wanted to investigate
whether impairment of type-2 immunity by IL-17A was unique to
the pulmonary environment. Initially we examined type-2 cytokine
gene expression in the small intestine of N. brasiliensis infected mice
at d7pi. However, we did not observe any significant changes in WT
infected mice (data not shown). We therefore decided to use
Trichuris muris, a nematode that establishes infection solely in the
gastro-intestinal tract. Infection with T. muris begins with the
ingestion of infective eggs that accumulate in the caecum. L1 larvae
hatch and penetrate the caecum and proximal colon wall, under-
going moults to L2 (d9-11pi), L3 (d17pi), L4 (d22 pi) and adults (d29-
32). High dose infection in C57BL/6 mice induces a strong type-2
response by d17pi, and subsequent clearance of the adult
parasites.22,23 We infected WT and Il17a-KO mice with a high dose
of 200 T. muris eggs and found worm counts in the caecum were
comparable between mouse strains at d19pi and d32pi (Fig. 5a),
indicating IL-17A does not alter parasite expulsion rate. Cell numbers
in the caecum were analysed and no differences in eosinophil and
neutrophil frequency were observed between Il17a-KO mice and WT
controls on d19pi and d32pi (Supplementary Fig. 2a, b), suggesting
an IL-17A-independent recruitment mechanism for both these cell
types in the large intestine. CD4+ T cell numbers in the mLN were
also comparable on d19pi and d32pi between Il17a-KO mice and
WT controls (Supplementary Fig. 2c). Although there was an
induction of type-2 cytokines in infected mice as measured by
intracellular cytokine staining, the numbers of IL-4, IL-5 or IL-13-
producing CD4+ T cells in the mLNs did not significantly differ
between the groups (Supplementary Fig. 2d). Similarly, the relative
expression of cytokines Il4, Il5 and Il13 did not differ between Il17a-
KO mice and WT controls within the caecum (Supplementary
Fig. 2e). Secreted levels of IL-5, IL-9 and IL-13 in MLN cells were also
not impaired in Il17a-KO mice relative to WT controls (Supplemen-
tary Fig. 2f). Together, these data failed to provide any evidence that
IL-17A was an important regulator of type-2 immunity in the
intestine or draining lymph nodes during T. muris infection.
Previous studies have shown that despite the restriction of the
T. muris lifecycle to the gastro-intestinal tract of the mammalian
host, evidence of a type-2 immune response can be observed at
distant sites, such as the lung.24 Therefore, the immune response
in the lung of T. muris infected WT vs Il17a-KO mice at d19pi and
d32pi was assessed. Neutrophils numbers were increased in
infected WT animals at d19pi and d32pi, but this was significantly
reduced in Il17a-KO mice on d19pi (Fig. 5b). No significant
changes were observed for eosinophils (Fig. 5c). Whilst lung CD4+
T cell numbers in infected animals did not change compared with
naïve controls (Fig. 5d), Il17a-KO mice had significantly fewer
IL-5+CD4+ T cells at d19 and d32pi compared with WT controls
(Fig. 5e). Although the effect on IL-13+CD4+ T cells was less
evident, infected Il17a-KO mice failed to significantly increase
numbers of IL-13+CD4+ T cells compared with uninfected controls
(Fig. 5e). Supporting the intracellular cytokine staining, qRT-PCR
analysis in whole lung tissue showed an impairment of type-2
cytokines in the Il17a-KO mice, with significantly decreased
expression of Il4 (d32pi) and Il5 (d19pi) (Fig. 5f).
Similar to infection with N. brasiliensis, we also observed an
upregulation of IFNγ in the lung during T. muris infection in Il17a-
KO mice. Both the number and the frequency of IFNγ+CD4+ T cells
Fig. 1 Mice deficient in IL-17A mount a diminished type-2 response at the site of infection. C57BL/6 (WT) and Il17a-KO mice were infected
with 250 N. brasiliensis L3s and cell frequencies and cytokines were measured at different time points post infection compared with WT naïve
mice. Frequencies of IL-17A-producing γδ T cells on d1pi and d2pi and representative flow-plot at d1pi (a). Worm burden in small intestine
assessed in WT and Il17a-KO mice on days 2, 4 and 6 post N. brasiliensis infection (b). Absolute numbers of neutrophils (Ly6G+CD11b+) (c) and
lung ILC2s (Lineage− KLRG+CD127+CD90.2+ST2+) as measured via flow cytometry (d). Relative mRNA expression of cytokine Il4 in whole lung
as quantified by qRT-PCR (log2 expression relative to actb (β-actin)) (e). Secreted IL-13 levels from unstimulated (us) or 72 h α-CD3 treated
single-suspension lung cells (f). Absolute numbers of live CD4+ T cells in lung tissue and lung draining lymph nodes (LdLN) (g). Frequency and
absolute numbers of GATA3+ CD4+ T cells in the lung (h). Representative flow-plots showing the frequency of IL-5 and IL-13 production by
CD4+ T cells d7pi in lung from WT and Il17a-KO infected mice (i). Absolute numbers of IL-5+ and IL-13+ CD4+ T cells in the lung (j). Expression
of CD69 on CD4+T cells and absolute numbers of EGFR+CD4+T cells, ST2+CD4+T cells and PD-1+CD4+T cells in lung (k) and LdLNs (l). Data are
representative (mean ± s.e.m.) of at least 3 individual experiments (a, c–l) or pooled data from three experiments (b). Data were tested
for normality using Shapiro-Wilk test and analysed using one-way ANOVA followed by Sidak’s multiple comparisons test for selected groups.
NS – not significant. Data in (e) were log2 transformed to achieve normal distribution and statistical tests were performed on transformed data
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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Fig. 2 Presence of IL-17A leads to a downregulation of early IFNγ during N. brasiliensis infection. Whole lung RNA from C57BL/6 (WT) and
Il17a-KO mice on d2pi with N. brasiliensis compared with WT naïve mice, were analysed by Nanostring. Unsupervised, hierarchically clustered
heat map showing significant differentially expressed genes between infected WT, Il17a-KO mice and uninfected (naïve) WT (a). Top
differentially regulated genes from (a) between infected WT and Il17a-KO mice were run in Ingenuity pathway analyzer, with top predicted
regulators shown in (b). Relative expression of Ifng in whole lung of naïve WT and d2 N. brasiliensis infected WT and Il17a-KO mice (log2
expression relative to actb (β-actin)) (c). Frequencies of IFNγ+ γδ T cells, CD4+ T cells, CD8+ T cells and NK cells in WT and Il17a-KO mice d2pi
compared with WT naïve mice as assessed by flow cytometry (d). Frequency of IFNγ+ γδ T cells 16 h post N. brasiliensis infection in WT and
Il17a-KO mice (e). Representative flow plots showing CD44 and CD27 γδ T cell subsets in naïve mice and mice 16 h post N. brasiliensis infection
as well as frequency of IFNγ+ CD27+ γδ T cells 16 h post N. brasiliensis infection in WT and Il17a-KO mice (f). Data (c–f) are expressed as mean ±
s.e.m. and are representative of at least 2 individual experiments with at least three mice per infected group. Data were tested for normality
using Shapiro-Wilk test and analysed using one-way ANOVA followed by Sidak’s multiple comparisons test for selected groups or student’s
t test. *P < 0.05, **P < 0.01.
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in the lung were significantly increased in Il17a-KO compared with
WT infected mice on d19pi (Fig. 5g). This data utilising T. muris
infection models suggests that IL-17A-dependent suppression of
IFNγ allows promotion of the type-2 immune response specifically
in the lungs but not the intestine and highlights means of
communication between the intestine and the lung involving
IL-17A, not previously described.
DISCUSSION
IL-17A, the key cytokine of the IL-17 family, is central to barrier
immunity, combating fungal infections and inducing antimicrobial
proteins as well as neutrophil activating and recruiting chemo-
kines.2 However, in the context of type-2 immunity, a combination
of type-2 cytokines and IL-17A is often a signature for severe
disease pathology. For example, IL-17A contributes to asthma
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Fig. 3 IFNγ neutralization in Il17a-KO mice rescues the impaired type-2 immune response. C57BL/6 (WT) and Il17a-KO mice and were treated
with α-IFNγ or isotype control on days −1 and 1pi with 250 L3 larvae of N. brasiliensis (a). Absolute numbers of eosinophils per mL of BAL (b) or
CD4+ T cells per gram lung tissue (c) as measured via flow cytometry on d8pi. Relative mRNA expression of type-2 cytokines Il4 and Il13 (d) and
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of EGFR+, ST2+ and PD1+ CD4+ T cells per gram lung tissue (h). Data (b, d, e–g) are representative (mean ± s.e.m.) of two individual experiments
with at least three mice per group (per experiment) or pooled data from two experiments (c, f). Data were tested for normality using Shapiro-Wilk
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pathology by enhancing IL-13 activity25 and a dysregulated
balance between IL-17A and type-2 responses exacerbates
pathology during schistosomiasis and onchocerciasis.4–6,26 Under-
standing the relationship between IL-17A and type-2 immune
responses is thus critical, and we and others have previously
demonstrated that development of a full type-2 response can
require IL-17A.8,12,13,27
In our effort to understand how IL-17A might be required for full
type-2 immunity, we have discovered that IL-17A suppresses early
IFNγ expression in the lung during helminth infection. Although
several studies show links between IL-17A and IFNγ, whether IFNγ
is up- or downregulated in response to IL-17A varies with setting,
timing and location. For example enhanced IFNγ in Il17a-KO mice
has been described in a viral infection,28 experimental visceral
leishmaniasis, and Toxoplasma gondii infection.29 Evidence also
exists in the context of helminth infection, where a lack of IL-17A
drives elevated IFNγ during infection with the filarial nematode
Litomosoides sigmondontis30 or Schistosoma japonicum31 and
Schistosoma mansoni.5 In contrast, IL-17A can promote IFNγ
production during kidney-ischaemic reperfusion injury,32 or
Francisella tularensis infection.33 Importantly, the consequence of
IL-17A-IFNγ cross-regulations in the context of type-2 inflamma-
tion has never been shown and here we reveal IFNγ
downregulation as a new mechanism through which IL-17A
establishes a protective type-2 response in the lung.
Another key finding of our study was that the requirement for
IL-17A to suppress IFNγ appears restricted to the lung. The
protective type-2 immune response in the gut of Il17a-KO mice
was not impaired, and mice were still able to expel N. brasiliensis
from the small intestine and T. muris from the colon. The more
surprising finding was that even though T. muris does not have a
lung stage, the concurrent type-2 response in the lung was
impaired in Il17a-KO mice. CD4+ T cells in the lung produced less
type-2 cytokines in the Il17a-KO mice and consistent with our
findings in N. brasiliensis, CD4+ T cells in Il17a-KO mice produced
significantly higher amounts of IFNγ than in their WT counterparts.
These findings raise major questions as to the nature of the insult
that induces IL-17 in the lungs of T. muris infected mice. Although
our data suggest that the impact of IL-17A on type-2 development
might be lung restricted, there may still be a fundamental
requirement for suppression of IFNγ for type-2 immunity to
progress. Artis et al. demonstrated that the type-2 immune
response during T. muris requires TSLP, and in very similar
experiments to those described here, demonstrated that TSLP
functions to suppress IFNγ.34 Thus, early suppression of IFNγ may
be a general pre-requisite for the development of a type-2
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environment with a requirement for IL-17A in the lung and TSLP
(or other factors) in the gut.
We have not yet addressed the full mechanism behind IL-17A-
mediated suppression of IFNγ during N. brasiliensis infection but it
is notable that IL-17A not only impairs type-2 cytokine production,
but also alters the cellular activation status and expression of type-
2 markers. Interestingly, in our model, we only observe impair-
ment of type-2 immune responses in the lung itself and not in the
Th2 cells from lung-draining lymph nodes. Expression of EGFR and
ST2, two markers closely associated with type-2 settings,16 were
reduced on the CD4+ T cells of Il17a-KO mice in the lung. EGFR
expression on Th2 cells is critical for resistance during GI helminth
infection and a signalling complex between EGFR and ST2 can
activate Th2 cells to secrete IL-13 in an antigen-dependent
manner upon IL-33 exposure. Our data would suggest that this
“licensing” of Th2 cells does not occur in the Il17a-KO mice during
N. brasiliensis infection, indicating that IL-17A is needed for a
proper induction of the adaptive Th2 response in the lung.
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Fig. 5 Lack of IL-17A impairs concurrent type-2 immune responses in the lung following infection with Trichuris muris. C57BL/6 WT and
Il17a-KO mice were infected with a high dose of T. muris and immune parameters investigated at d19 and d32pi compared with uninfected
(naïve) C57BL/6 WT and Il17a-KO mice. Worms counts in the caecum (a). Absolute numbers of neutrophils (b), eosinophils (c) and CD4+ T cells
(d) per gram of lung at d19pi and d32pi compared with naïve mice. Absolute numbers of IL-5+ and IL-13+ CD4+ T cells per gram of lung
tissue (e). Relative mRNA expression of cytokines Il4 and Il5 from whole lung (log2 expression relative to actb (β-actin)) of infected mice (f).
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It is well documented that type-2 responses are essential to
limit excessive IL-1735–37 but a novel finding from our study is that
the reverse is also true. While the early γδ T cell-derived IL-17A
supported the type-2 response, late IL-17A, derived from both
Th17 cells and γδ T cells, negatively regulated type-2 cytokines. To
our knowledge, IL-17A suppression of type-2 cytokines has not
previously been described in vivo and illustrates a major cross-
regulatory axis between type-2 cytokines and IL-17A, each
required to contain the excessive production of the other. In the
numerous situations in which a combination of type-2 cytokines
and IL-17A results in severe disease pathology,4,6,25 it is apparent
that this cytokine balance has failed. Together our data
demonstrate that early events in the lung shape the protective
type-2 immune response, with IL-17A as a critical regulator of
type-2 immunity. IL-17A, as a driver of tissue damage,8 may itself
be needed to establish a subsequent type-2 repair response.
However, the ability of IL-17A to then suppress type-2 responses,
reveal an important feedback loop that must go awry during
severe asthma and other type-2 conditions in which IL-17A plays a
damaging and pathogenic role. Finally, in combination with
previous data,34 suppression of IFNγ at barrier sites may be a
central paradigm for type-2 immunity.
MATERIALS AND METHODS
Mice and ethics statement
For experiments using only WT mice, C57BL/6 J mice were
obtained from Charles River. C57BL/6 Il17aCreRosa26eYFP mice
were originally provided by Dr Brigitta Stockinger.38,39 For Il17a-KO
experiments C57BL/6 WT mice and C57BL/6 Il17aCreRosa26eYFP
homozygote mice were bred at the University of Manchester. Mice
were age- and sex-matched and all mice were housed in
individually ventilated cages. Both males and females were used.
Mice were not randomized in cages, but each cage was randomly
assigned to a treatment group. Mice were culled by asphyxiation
in a rising concentration of CO2. Experiments were performed in
accordance with the United Kingdom Animals (Scientific Proce-
dures) Act of 1986.
N. brasiliensis infection
N. brasiliensis was maintained by serial passage through Sprague-
Dawley rats, as described.40 Third-stage larvae (L3) were washed
ten times with PBS (Dulbecco’s PBS, Sigma) before infection. On
day 0, mice were infected subcutaneously with 250 or 500 larvae
(L3). At various time points mice were euthanised, BAL was
performed with PBS containing 1% BSA and lungs were taken for
further analysis. For worm counts, the small intestines of infected
mice were collected in PBS. Small intestines were then cut
longitudinally along the entire length, placed in a 50ml Falcon
and incubated at 37 °C for 4 h. Settled worms were then counted
with the aid of a dissecting microscope.
Flow cytometry
Single-cell suspensions of the lung were prepared by digesting
minced lung lobes for 30min at 37 °C with 0.2 U/ml Liberase TL
(Roche) and 80 U/ml DNase (Life Tech) in Hank’s balanced-salt
solution before forcing tissue suspensions through a cell strainer
(70 µm, Greiner). Red blood cells were lysed using Red Blood Cell
Lysing Buffer Hybri Max (Sigma) for 3 min at RT and reaction was
stopped by diluting samples in PBS. Total live cells were counted
with AO/PI dye on an automated cell counter (Auto2000,
Nexcelom). Cells were stained for live/dead (Life Technologies)
and then incubated with Fc-block (1:500 CD16/CD32 and 1:50
mouse serum) and were then stained with fluorescence-
conjugated antibodies. Cells were identified by expression of
surface markers as follows: neutrophils Ly6G+CD11b+, eosinophils
CD11b+ CD11c− SigF+, CD4 T cells CD4+, TCRβ+CD11b−, γδ Tcells
TCRβ−, TCRγδ+, CD11b− and ILC2s Lineage− (CD11b, TCRβ, TCRγδ,
Ly6G, F4/80, CD11c, SigF, CD19) CD90.2+KLRG+CD127+. Antibody
clones used are listed in Table 1. For staining of intracellular
cytokines, cells were stimulated for 4 h at 37 °C with cell
stimulation cocktail containing protein transport inhibitor
(eBioscience), then stained with live/dead. After surface antibody
staining, cells were fixed for 10min at 4 °C using IC fix (Biolegend)
and cells were then incubated in for 20 min at RT in Permeabiliza-
tion buffer (biolegend). Intracellular staining was performed for
cytokines using antibodies for IL-5, IL-13, IL-17A and IFNγ as well
as for Gata3 and Ym1. Samples were analysed by flow cytometry
with LSR Fortessa or LSR II (Becton-Dickinson) and data analysed
using FlowJo v10 software.
Quantification of cytokines
Single-cell suspensions of splenocytes, lung-draining lymph nodes
or whole lung were stimulated ex vivo with N. brasiliensis excretory
secretory product (E/S) antigen41 (1 μg/ml) or anti-CD3 (1 μg/ml).
Cell supernatants were harvested 72 h later and were stored at
−20 °C until further analysis. Mouse IL-13 DuoSet ELISA kit (R&D
Systems) was used for measurement of IL-13 levels. Mesenteric
lymph node (MLN) cells from T. muris infected or uninfected mice
were collected, cultured and restimulated ex vivo for 36 h with E/S
as previously described.22 The concentrations of IL-5, IL-6, IL-9,
IL-10, IL-13, IL-17A, TNFα and IFNγ in the mLN culture supernatant
were measured by cytokine bead array (CBA, BD Biosciences, UK)
as per the manufacturer’s protocol.
Antibody depletion experiments
IFNγ was depleted using an anti-IFNγ monoclonal antibody (clone
XMG1.2) and injected intraperitoneally (500 μg/mouse/day) on
days −1 and 1 of infection with N. brasiliensis. Control mice were
injected with an equal amount of corresponding isotype control
(GL113). IL-17A was depleted using an anti-IL-17A (17F3) or IgG1
isotype (both Invivo mAB) injected intraperitoneally (100 μg/
mouse/day) on days 4, 5 and 6 post-infection with N. brasiliensis.
Table 1. List of flow cytometry antibodies used.
Antigen Clone Manufacturer
CD11b M1/70 BioLegend
CD11c N418 BioLegend
Ly6C HK1.4 BioLegend
CD4 GK1.5 BioLegend
F4/80 BM8 eBioscience
CD90.2 30-H12 Biolegend
CD127 A7R34 Invitrogen
KLRG1 2F1 Biolegend
TCRβ H57-597 BioLegend
TCRγδ GL3 BioLegend
ST2 DIH9 BioLegend
IL-5 TRFK5 BioLegend
IL-17A TC11-18H10.1 BioLegend
Ly6G 1A8 BD Biosciences
Siglec-F E50-2440 BD Biosciences
F4/80 BM8 ThermoFisher
IL-13 eBio13A ThermoFisher
Ym1 Polyclonal R&D Systems
RELM-α Polyclonal Peprotech
IFNγ XMG1.2 Biolegend
CD69 H1.2F3 Biolegend
GATA3 16E10A23 Biolegend
EGFR EGFR1 Abcam
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Extraction of RNA and quantitative real-time PCR
A fragment of the right lung lobe was stored in RNAlater (Ambion)
before homogenization of tissue in Qiazol reagent with a
TissueLyser (Qiagen). RNA was prepared according to manufac-
turer’s instructions. RNA was quantified using a ND-1000 Spectro-
photometer (NanoDrop Technologies). Reverse transcription of
1 μg of total RNA was performed using Tetro reverse transcriptase
(Bioline). For reverse transcription, total RNA was treated with 50 U
Tetro reverse transcriptase (Bioline), 40 mM dNTPs (Promega),
0.5 μg PolyT primer for cDNA synthesis (Roche) and RNasin
inhibitor (Promega). The abundance of transcripts from the genes
of interest was measured by quantitative real-time PCR with the
Light Cycler 480 II system (Roche) with a Brilliant III SYBR master
mix (Agilent) and specific primer pairs. PCR amplification was
analysed by the second-derivative maximum algorithm (Light
Cycler 480 Sw 1.5; Roche), and expression of the gene of interest
was normalized to that of the housekeeping gene Actb (beta-
actin). A list of primer sequences used are shown in Table 2.
Trichuris muris infection and E/S products
T. muris eggs were prepared from chronically infected stock mice
as described previously.42 Mice were infected by oral gavage with
200 embryonated T. muris eggs suspended in ddH2O. At day 19
and 32 post infection, T. muris burden was assessed by removing
the caecum and proximal colon, opening them longitudinally and
scraping the contents out with fine forceps. Individual worms
were then counted by eye under a binocular dissecting
microscope. T. muris adult excretory secretory product antigen
(E/S) was prepared as described by.42 In brief, adult T. muris were
cultured ex vivo at 37 °C, the culture supernatant was collected
and centrifuged to remove eggs and worms. The resultant
supernatant was then filter sterilised and stored at −20 °C until
use for in vitro re-stimulation of MLN cells.
Nanostring RNA profiling
Extracted RNA was run on an Agilent 2200 Tape Station system to
ensure high quality lung RNA; samples with a RIN value of <6.5
were excluded. Suitable RNA was then diluted to 20 ng/μL in
RNase free H2O, measured using Qubit™ RNA HS Assay Kit
(Thermofisher) and run on a Nanostring nCounter® FLEX system
using the Myeloid Innate Immunity v2 panel (XT-CSO-MMII2-12)
220 as per manufacturer’s instructions. Raw data were loaded into
nSolver version 4.0 using default settings. Non-normalised counts
were then exported and subsequent analyses were performed in R
(version 3.6) using RStudio Version 1.2.1335 Build 1379 – ©
2009–2019 RStudio, Inc. Positive controls were analysed to ensure
there was clear resolution at variable expression levels and
negative controls were used to set a minimum detection
threshold which was applied to all samples. Data were then
normalised with EdgeR using the TMM method and differential
expression between N. brasiliensis-infected WT and Il17a-KO mice
was calculated via linear modelling with Empirical Bayes smooth-
ing using the limma R package 2.43 Genes with an absolute fold
change of greater than one and a significance value of under 0.05
after correction for multiple comparisons using the Benjamini-
Yekeuteli method were defined as “differentially expressed”
and taken forward for further analysis. Heatmaps were then
generated from normalized counts of DE genes using the
ComplexHeatmaps R package. The networks and functional
analyses of DE genes were generated with Ingenuity pathway
analyser (QIAGEN Inc., https://www.qiagenbio-informatics.com/
products/ingenuity-pathway-analysis). Data were then imported
into R for visualisation.
Statistics
Prism 7.0 (version 7.0c, GraphPad Software) was used for statistical
analysis. Differences between experimental groups were assessed
by ANOVA (for normally distributed data, tested using Shapiro-
Wilk normality test) followed by Sidak’s multiple comparisons test.
For gene expression data, values were log2 transformed to achieve
normal distribution. Comparisons with a P value < 0.05 were
considered to be statistically significant. Data are represented as
mean ± sem.
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